Acorah Software Products - Accounts Production 19.2.450 false true false true No description of principal activity 23 July 2024 31 July 2025 31 July 2025 15855037 C Hill iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15855037 2024-07-22 15855037 2025-07-31 15855037 2024-07-23 2025-07-31 15855037 frs-core:CurrentFinancialInstruments 2025-07-31 15855037 frs-core:Non-currentFinancialInstruments 2025-07-31 15855037 frs-bus:PrivateLimitedCompanyLtd 2024-07-23 2025-07-31 15855037 frs-bus:FilletedAccounts 2024-07-23 2025-07-31 15855037 frs-bus:Micro-entities 2024-07-23 2025-07-31 15855037 frs-bus:AuditExempt-NoAccountantsReport 2024-07-23 2025-07-31 15855037 frs-bus:Director1 2024-07-23 2025-07-31
Registered number: 15855037
Pink Venom Limited
Financial Statements
For the Period 23 July 2024 to 31 July 2025
Balance Sheet
Registered number: 15855037
31 July 2025
£
Fixed assets 30,884
Current assets 114
Creditors: Amounts Falling Due Within One Year (26,809 )
NET CURRENT LIABILITIES (26,695 )
TOTAL ASSETS LESS CURRENT LIABILITIES 4,189
Creditors: Amounts Falling Due After More Than One Year (12,033 )
NET LIABILITIES (7,844 )
CAPITAL AND RESERVES (7,844 )

Notes

1. General Information
Pink Venom Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15855037 . The registered office is 17 Chasecliff Close, Chesterfield, S40 4HR.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
C Hill
Director
22/07/2026